The use of dermoscopy improves the diagnosis of skin cancer significantly in trained dermatologists. However, to evaluate its cost-effectiveness in daily practice, not only sensitivity but also the excision rate is important.
Introduction
The skin cancer epidemic has an important impact on health care budget. Early detection and treatment is assumed to give better cure rates and subsequently a more cost-effective treatment. Dermoscopy is a well-established technique for diagnosis of melanoma and nonmelanoma skin cancer. Several meta-analyses have shown that dermoscopy, in the hands of experienced dermatologists, is superior to naked-eye examination (NEE) to detect melanoma [1] [2] [3] . Dermoscopy also significantly increases the diagnostic accuracy of nonmelanoma skin cancer diagnosis [4] . For basal cell carcinoma (BCC) the dermoscopic diagnostic accuracy is up to 95%-99% [5] [6] [7] .
It is known that the diagnostic accuracy of dermoscopy depends significantly on training of the examiners [8] . In the hands of untrained practitioners, dermoscopy provides no better diagnostic accuracy for melanoma than NEE [1] .
Most of the studies on the additional diagnostic value of dermoscopy have been performed in a well-selected set of lesions, in which melanomas and other malignant lesions are usually overrepresented. Since skin cancer prevalence in real-life setting is usually much lower, this can influence the number of false-positive diagnoses and their related cost in an important way (Bayes' theorem). For this reason we examined diagnostic accuracy and treatment allocation by NEE alone and additional dermoscopy among dermatologists in a population-based screening sample in Belgium.
Methods

Study Design
Cases and Determination of Reference Diagnosis
The cases were collected during a population-based lesiondirected skin cancer screening. Screenees could register for a free-of-charge skin cancer check-up if they had a lesion meeting 1 or more of the following criteria: ABCD rule, ugly duckling sign, a new lesion lasting more than 4 weeks, or red nonhealing lesions. All the index lesions presented by the screenees were checked and photographed both clinically and dermoscopically, respectively with an EOS 1200 D camera (Canon, Giessen, Germany) and the DermLite Photo System (3Gen, San Juan Capistrano, CA, USA). Following this lesion-directed screening, a total body check was offered to all participants for ethical reasons. We did not photograph any lesions during this second phase of the screening. In total 248 lesions were screened and 8 of them were histologically proven to be skin cancers (3.2%). Further details on this screening initiative have been published elsewhere [9] . In total 145 of the 248 cases (58%) were selected for a web application. Exclusion of cases was due to suboptimal quality of the photographs or a missing clini- shown the clinical picture and were asked to select a clinical diagnosis (multiple choice), to score the certainty of their diagnosis on a visual analogue scale from 0 to 100%, and to choose the best treatment action (no treatment, biopsy, surgical excision, curettage, cryotherapy, and other); after registration of these answers they were shown the dermoscopy photograph and were asked to complete the same questions.
Sample Size Calculation and Statistical Analysis
A sample size of 1,630 case evaluations was required to 
Outcomes
The primary outcome of this study was to evaluate the diagnostic accuracy of dermoscopy compared with NEE in a population-based setting. Furthermore, we wanted to evaluate whether dermoscopy can increase certainty of the correct diagnosis.
Results
Participant Characteristics
In 
Diagnostic Accuracy and Certainty of Diagnosis
Dermoscopy increased sensitivity for skin cancer diagnosis significantly from 70.6% to 84.6% (binomial generalized linear mixed model, P = 0.002; Table 2 ), associated with a small but significant decrease in specificity (96.9% for NEE vs 93.5% for dermoscopy, binomial generalized linear mixed model, P < 0.001; Figure 1 ). The sensitivity for the diagnosis 
Discussion
In this study the additional value of dermoscopy over NEE diagnosis by 126 dermatologists was evaluated in a population-based series of 145 cases. In the past many similar studies have used very selected case series in which skin cancer was usually overrepresented. Although the intention is not to miss any skin cancer (100% sensitivity), especially in melanoma, the importance of not overdiagnosing skin cancer (high specificity) may also be an important issue to avoid the individual (fear, unnecessary intervention) and societal (cost) disadvantages of false-positive diagnoses. In non-highrisk populations the specificity will have a higher impact on cost-effectiveness. In this study we therefore included a case series based on a population-based lesion-directed skin cancer screening program, in which skin cancer prevalence was only 6/145 (4.1%). Nearly one third of all Flemish dermatologists evaluated at least 25 of the 145 cases. Cases were randomly presented to the participants, leading to a total of 4,655 case evaluations. In this way this study reflects the additional value of dermoscopy in the hands of general dermatologists in a population-based setting.
The results of this study demonstrate that dermoscopy is frequently used in Belgian dermatology practice: almost 90% of participants use their dermatoscope daily. This is comparable with large studies performed in France and Australia (94.6%-98%) [11, 12] .
In accordance with other studies, we observed that dermoscopy significantly increases sensitivity for malignant lesions [1] [2] [3] [4] 6] . However, this results also in a small but sig- ing showed no change, hence suggesting that these lesions have a benign behavior. This finding illustrates that some of the false-positive skin cancer diagnoses may have been due to the artificial conditions in which these lesions were evaluated.
Compared with previous studies, a NNE of 1 out of 6 was obtained in this study. Evaluation of the large SCREEN campaign in Germany in a partially nonspecialized setting not using dermoscopy resulted in 17 excisions of melanocytic lesions for the detection of 1 melanoma [13] . Our data are comparable with those of a large multicentric study examining excision rates over a period of 10 years in specialized clinical settings, with a NNE of 6.8 [14] . There was a trend toward increased sensitivity and specificity with increased training; however, training of >10 hours did not reach statistically significant superior results. In the recent NICE guidelines it is recognized that dermoscopy is unequivocally useful in the diagnosis of melanoma, but only in the hands of trained users [15] . The required amount of training, however, is a topic of debate. It has been shown that despite the frequent use of dermoscopy, training seems to be insufficient and that even among dermatologists who consider themselves experienced in dermoscopy, repeated training can increase diagnostic accuracy [8, 11] . In addition, currently a lot of training courses in dermoscopy mainly focus on red flags (increased sensitivity for melanoma). However, when used in low-prevalence populations, it could be interesting to put more focus on green flags (recognition of harmless lesions), thereby reducing the number of false-positive diagnoses and hence unnecessary excisions.
Conclusions
The current study evaluated the additional value of dermoscopy in the hands of general dermatologists in a populationbased setting using a series of photos in a web application.
These results demonstrate that dermoscopy clearly increases sensitivity for malignant lesions in a population-based setting at the expense of a small but significant decrease in specificity. Although dermoscopy significantly increased confidence about a diagnosis, especially in melanoma, seborrheic keratosis and Bowen disease, this did not result in a reduction of NNE. There was a trend toward higher sensitivity and specificity according to training level (<5 hours, 5-10 hours, or >10 hours). We suggest that continuous training for dermoscopy is necessary and that training courses should also pay enough attention to the recognition of benign lesions to avoid unnecessary excisions and in that way benefit costeffectiveness ratios.
